Insider Transactions in Q2 2022 at Zai Lab LTD (ZLAB)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
Du Ying Chairperson & CEO |
SELL
Bona fide gift
|
Direct |
120,000
-12.26%
|
-
|
|
Apr 01
2022
|
Du Ying Chairperson & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
828
-0.08%
|
$37,260
$45.47 P/Share
|
|
Apr 01
2022
|
Harald Reinhart |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-0.98%
|
$11,070
$45.47 P/Share
|
|
Apr 01
2022
|
Alan B. Sandler Head of Global Dev., Oncology |
BUY
Exercise of conversion of derivative security
|
Direct |
1,060
+3.53%
|
-
|
|
Apr 01
2022
|
Yi Liang CCO & President, Greater China |
BUY
Exercise of conversion of derivative security
|
Direct |
730
+0.69%
|
-
|
|
Apr 01
2022
|
Du Ying Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,400
+0.33%
|
-
|
|
Apr 01
2022
|
Harald Reinhart |
BUY
Exercise of conversion of derivative security
|
Direct |
1,010
+3.87%
|
-
|
|
Apr 01
2022
|
Frazor Titus Edmondson Iii Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+3.36%
|
-
|
|
Apr 01
2022
|
William Ki Chul Cho Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
920
+1.77%
|
-
|